Evogene Ltd. — Form SCHEDULE 13D
Filed August 11, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 18/100
What the filing says
Schedule 13D filed 2026-08-11 by Recanati Leon (address: Herzelia, Israel) regarding beneficial ownership stake in Evogene Ltd. (CIK 0001574565, incorporated Israel, SIC 2870 Agricultural Chemicals). Filing documents the acquisition of beneficial ownership but specific share count, percentage owned, purchase price, and transaction date are not visible in the header metadata provided.
Why this rating
Header metadata only; no deal terms, shareholding %, or dollar amounts disclosed in excerpt. Cannot assess materiality without substantive filing content.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.